Patrick Texereau
Impact in
- Oncology top 1%
- Pancreatic and Hepatic Oncology Research
- Colorectal Cancer Treatments and Studies
- COVID-19 and healthcare impacts
- Cancer Immunotherapy and Biomarkers
- Colorectal Cancer Surgical Treatments
- Cancer Research top 10%
Papers in
- Oncology 17
- Colorectal Cancer Treatments and Studies 13
- Pancreatic and Hepatic Oncology Research 3
- Neutropenia and Cancer Infections 1
-
- Hepatitis C virus research 1
- Co-authors
- Olivier Bouché (5 shared papers)Catherine Lombard‐Bohas (2 shared papers)Ahmed Azzedine (2 shared papers)Dany Gargot (2 shared papers)Mohamed Gasmi (2 shared papers)Michel Pierre Ducreux (3 shared papers)Pierre-Luc Etienne (3 shared papers)Laurent Bedenne (1 shared paper)
In The Last Decade
Patrick Texereau
26 papers receiving 3.3k citations
Patrick Texereau's Hit Papers
Peers
Comparison fields: 5 of 82
- Oncology 2.6k
- Cancer Research 132
- Geriatrics and Gerontology 22
- Radiology, Nuclear Medicine and Imaging 128
- Hepatology 45
Countries citing papers authored by Patrick Texereau
This map shows the geographic impact of Patrick Texereau's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patrick Texereau with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patrick Texereau more than expected).
Fields of papers citing papers by Patrick Texereau
This network shows the impact of papers produced by Patrick Texereau. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patrick Texereau. The network helps show where Patrick Texereau may publish in the future.
Co-authors
The 25 scholars most cited alongside Patrick Texereau, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 26 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer Hit paper breakdown → | 2018 | 2184 |
| 2 | Five-Year Outcomes of FOLFIRINOX vs Gemcitabine as Adjuvant Therapy for Pancreatic Cancer Hit paper breakdown → | 2022 | 225 |
| 3 | 2011 | 127 | |
| 4 | 2020 | 125 | |
| 5 | 2019 | 110 | |
| 6 | 2017 | 90 | |
| 7 | 2013 | 86 | |
| 8 | 2015 | 78 | |
| 9 | 2018 | 74 | |
| 10 | 2021 | 42 | |
| 11 | 2017 | 41 | |
| 12 | 2018 | 38 | |
| 13 | 2018 | 31 | |
| 14 | 2014 | 15 | |
| 15 | 2020 | 14 | |
| 16 | 2005 | 8 | |
| 17 | [A case of acute agranulocytosis in a patient treated with ranitidine]. | 1987 | 5 |
| 18 | 2013 | 5 | |
| 19 | 2020 | 5 | |
| 20 | 2018 | 3 |
About Patrick Texereau
Patrick Texereau is a scholar working on Oncology, Hepatology, Pathology and Forensic Medicine, Surgery and Genetics, having authored 26 papers that have together received 3.3k indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (13 papers), Pancreatic and Hepatic Oncology Research (3 papers), Genetic factors in colorectal cancer (2 papers), Neutropenia and Cancer Infections (1 paper), Economic and Financial Impacts of Cancer (1 paper), Hepatitis C virus research (1 paper), Colorectal and Anal Carcinomas (1 paper) and Helicobacter pylori-related gastroenterology studies (1 paper). The work is most often cited by research in Oncology (2.6k citations), Cancer Research (132 citations), Geriatrics and Gerontology (22 citations), Radiology, Nuclear Medicine and Imaging (128 citations) and Hepatology (45 citations). Patrick Texereau has collaborated with scholars based in France, Belgium and Canada. Frequent co-authors include Olivier Bouché, Catherine Lombard‐Bohas, Ahmed Azzedine, Dany Gargot, Mohamed Gasmi, Michel Pierre Ducreux, Pierre-Luc Etienne, Laurent Bedenne, Dominique Auby and David Malka. Their work appears in journals such as European Journal of Cancer, Annals of Oncology, Clinical Colorectal Cancer, The Lancet Oncology and New England Journal of Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.